首页 › 多发性骨髓瘤 › 加利福尼亚州 › Sacramento
Sacramento CA 多发性骨髓瘤临床试验
8项针对 多发性骨髓瘤的研究正在 Sacramento及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
招募中3 期
- Research Site, Sacramento
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Kaiser Permanente - Sacramento Medical Center, Sacramento
- Sutter Sacramento, Sacramento
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
招募中观察性研究
- University of California Davis Comprehensive Cancer Center, Sacramento
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
招募中3 期
- University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
- University of California, Sacramento
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Mercy Cancer Center - Sacramento, Sacramento
- Woodland Memorial Hospital, Woodland · 距离 16 英里
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
招募中1 期
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Mercy Cancer Center - Sacramento, Sacramento
- University of California Davis Comprehensive Cancer Center, Sacramento
- Woodland Memorial Hospital, Woodland · 距离 16 英里
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
招募中3 期
- University of California-Davis Cancer Center, Sacramento
其他城市的 多发性骨髓瘤试验
- New York City, NY60 项研究
- Atlanta, GA42 项研究
- Boston, MA42 项研究
- Houston, TX38 项研究
- Durham, NC37 项研究
- Nashville, TN32 项研究
- Denver, CO27 项研究
- Rochester, MN24 项研究
- St. Louis, MO24 项研究
- Columbus, OH24 项研究
- Baldwin Park, CA23 项研究
- Edison, NJ22 项研究
Sacramento的其他研究
- 非小细胞肺癌29 项研究
- 肺癌22 项研究
- 乳腺癌20 项研究
- 前列腺癌19 项研究
- 转移性癌症16 项研究
- 急性髓系白血病12 项研究
- 心力衰竭12 项研究
- 胰腺癌12 项研究
- 癌症（所有类型）11 项研究
- 结肠癌11 项研究
- 膀胱癌10 项研究
- 结直肠癌10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。